Dr. Andreadis, named AAAS fellow


Published February 15, 2023


UB CBE faculty member Stelios T. Andreadis has been elected fellow of the American Association for the Advancement of Science (AAAS), the world's largest general scientific society and publisher of the Science family of journals.

The lifetime honor is bestowed on AAAS members by their peers for his scientifically or socially distinguished efforts to advance science applications. He was among more than 500 scientists, engineers and innovators to receive the prestigious distinction this year. Past honorees include W.E.B. DuBois, Ellen Ochoa, Steven Chu, Grace Hopper, Alan Alda, Mae Jemison and Ayanna Howard.

AAAS fellow will be recognized in the journal Science in February and will be celebrated in an induction ceremony to be held this summer.

Stelios Andreadis.

Stelios Andreadis, SUNY Distinguished Professor of chemical and biological engineering, and biomedical engineering, is an internationally recognized leader in the field of stem cell engineering, especially cardiovascular tissue engineering. His pioneering work has led to engineering tissues for regenerative medicine, such as bioengineered arteries and veins, skin, skeletal muscle and salivary glands; and improved sources of stem cells and novel biomaterials (elastomers, hydrogels) for cell, gene and protein delivery for tissue regeneration.

More recently, his work has led to improved understanding of vascular and skeletal muscle aging and how to reverse it, shedding light into the role of the immune system in endothelialization of bioengineered arteries and resulting in real-world products to replace arteries in patients.

His research interests span a wide spectrum, from fundamental to technological to pre-clinical/translational research. It is highly interdisciplinary and is facilitated by collaboration with researchers across UB, including from the Jacobs School of Medicine and Biomedical Sciences, the School of Dental Medicine, UB’s New York State Center of Excellence in Bioinformatics and Life Sciences, and the Department of Biomedical Engineering, as well as Roswell Park Comprehensive Cancer Center.

Andreadis co-founded Angiograft LLC to commercialize the cell-free vascular grafts that were developed in his laboratory as arterial replacement grafts for treatment of cardiovascular disease.

He has received more than $25 million in research support from public and private sources, including the National Institutes of Health, National Science Foundation, NYSTEM and private foundations. He has published over 140 peer-reviewed publications and delivered more than 90 invited seminars. He has advised 35 PhD students, 21 MS students, 7 postdoctoral research fellows and more than 50 undergraduate researchers.

Andreadis is the director of the UB Cell, Gene and Tissue Engineering Center, and served as director of the Stem Cells in Regenerative Medicine (SCiRM) Training Program, which was funded by NYSTEM to train students in stem cell biology and bioengineering, and applications of stem cells in regenerative medicine. He also served as chair of the Department of Chemical and Biological Engineering from 2012-18.

He has received numerous accolades, including being elected as a fellow of the Biomedical Engineering Society (BMES), the American Institute of Chemical Engineers (AIChE) and the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE). He received the Excellence in Graduate Student Mentoring Award from UB in 2018, a SUNY Chancellor’s Award for Scholarship and Creative Activities in 2014, an NSF CAREER Award in 2000 and a Whitaker Foundation Young Investigator Award in 1999.